biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > JD really took his lapdogs to the woodshed.

<< Previous

Bullboard Posts

Next >>

Comment by craighenryon Dec 13, 2022 11:32am

89 Views

Post# 35168552

RE:RE:RE:RE:RE:JD really took his lapdogs to the woodshed.

craighenry wrote:
KayakerBC wrote: So is this it?
"exchange .9556 Midatech share for each BTI share."
"BTI trading at .18 cents. MTP at 1.25."

I don't know. I'm not clear on the exchange.
I don't know what "new shares of 0.1p each" means.

"Deal to be satisfied by issue of 75.9m new shares of 0.1p each in co capital at exchange ratio of 0.9556 shares for each bioasis share" -- Reuters

Kayaker .1p = .1 Pound

Midatech is located in the UK.